Dermatology · New Brighton, MN
Dermatology and skin studies in New Brighton, MN
4 recruiting studies have a site in New Brighton.
4 recruiting studiesSource: ClinicalTrials.gov, refreshed October 26, 2026How we list studies
Studies
- RecruitingPhase 2/Phase 3
Phase 2/3 Efficacy and Safety of PP405 in Adult Males
Pelage Pharmaceuticals, Inc.
- Location
- New Brighton, MN + 26 other US sites
- Eligibility basics
- Ages 18–55 · Men only
- RecruitingPhase 3
Long-Term Safety Study of Deucravacitinib Versus Ustekinumab in Participants With Psoriasis (PRAGMATYK)
Bristol-Myers Squibb
- Location
- New Brighton, MN + 90 other US sites
- Eligibility basics
- Ages 40+
- RecruitingPhase 2
ORKA-002 Versus Placebo in Participants With Moderate-to-Severe Hidradenitis Suppurativa
Oruka Therapeutics, Inc.
- Location
- New Brighton, MN + 13 other US sites
- Eligibility basics
- Ages 18–79
- RecruitingPhase 2
Study of the Efficacy and Safety of ICP-332 in Participants With Prurigo Nodularis
Beijing InnoCare Pharma Tech Co., Ltd.
- Location
- New Brighton, MN + 13 other US sites
- Eligibility basics
- Ages 18–75
Who these studies look for
Most require an active, diagnosed skin condition of a certain severity and a pause on some current treatments before starting.
Matching a page like this one never means you qualify. Each research team decides eligibility at screening.